In vitro residual activity of phenylalanine hydroxylase variants and correlation with metabolic phenotypes in PKU.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Gene

• Publication date

  2016-12-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.gene.2016.09.015PMID 27620137
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• First structure of full-length mammalian phenylalanine hydroxylase reveals the architecture of an autoinhibited tetramer

  2016cited by this paper
• Co-expression of phenylalanine hydroxylase variants and effects of interallelic complementation on in vitro enzyme activity and genotype-phenotype correlation.

  2016cited by this paper
• Molecular genetics and diagnosis of phenylketonuria: state of the art

  2014cited by this paper
• Mutation analysis in hyperphenylalaninemia patients from South Italy.

  2013cited by this paper
• Quantification of phenylalanine hydroxylase activity by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry.

  2012cited by this paper
• Phenylalanine hydroxylase deficiency

  2011cited by this paper
• Phenylketonuria.

  2010cited by this paper
• Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria.

  2008cited by this paper
• Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study.

  2007cited by this paper
• The PAH gene, phenylketonuria, and a paradigm shift

  2007cited by this paper
• The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study

  2007cited by this paper
• The spectrum of phenylalanine variations under tetrahydrobiopterin load in subjects affected by phenylalanine hydroxylase deficiency

  2006cited by this paper
• Kinetic and stability analysis of PKU mutations identified in BH4-responsive patients.

  2005cited by this paper
• Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study.

  2005cited by this paper
• Incidence of BH4-responsiveness in phenylalanine-hydroxylase-deficient Italian patients.

  2005cited by this paper
• Phenylketonuria: Genotype–phenotype correlations based on expression analysis of structural and functional mutations in PAH

  2003cited by this paper
• Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria.

  2002cited by this paper
• In vitro expression of 34 naturally occurring mutant variants of phenylalanine hydroxylase: correlation with metabolic phenotypes and susceptibility toward protein aggregation.

  2001cited by this paper
• Phenotypes of patients with "simple" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics.

  2000cited by this paper
• Human phenylalanine hydroxylase gene expression in kidney and other nonhepatic tissues.

  1999cited by this paper
• Monogenic traits are not simple: lessons from phenylketonuria.

  1999cited by this paper
• Phenylketonuria splice mutation (EXON6nt‐96Ag) masquerading as missense mutation (Y204C)

  1997cited by this paper
• Missense mutations prevalent in Orientals with phenylketonuria: molecular characterization and clinical implications.

  1991cited by this paper
• Hyperphenylalaninaemia caused by defects in biopterin metabolism

  1985cited by this paper

• Significance of utilizing in silico structural analysis and phenotypic data to characterize phenylalanine hydroxylase variants: A PAH landscape.

  2024cites this paper
• Carriers of autosomal recessive conditions: are they really ‘unaffected?’

  2023cites this paper
• Screening of 1.17 million newborns for inborn errors of metabolism using tandem mass spectrometry in Shanghai, China: A 19-year report.

  2023cites this paper
• The pathogenicity classification of PAH gene variants in the Iranian population

  2022cites this paper
• Deubiquitinase USP19 extends the residual enzymatic activity of phenylalanine hydroxylase variants

  2022cites this paper
• Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine Patients

  2019cites this paper
• Characterization Of Patients Diagnosed With Phenylketonuria In The Neonatal Treatment Reference Service

  2019cites this paper
• Charakterisierung eines Mausmodells zur BH4-sensitiven Phenylketonurie

  2019cites this paper
• Genotype‐phenotype correlations and BH4 estimated responsiveness in patients with phenylketonuria from Rio de Janeiro, Southeast Brazil

  2019influential citation
• Current trends in site and target specific delivery of nanomedicine for gene therapy

  2019cites this paper
• In vitro residual activities in 20 variants of phenylalanine hydroxylase and genotype-phenotype correlation in phenylketonuria patients.

  2019cites this paper
• Comparative analysis of functional assay evidence use by ClinGen Variant Curation Expert Panels

  2019cites this paper
• Secondary BH4 deficiency links protein homeostasis to regulation of phenylalanine metabolism

  2018cites this paper
• Unique aspects of sequence variant interpretation for inborn errors of metabolism (IEM): The ClinGen IEM Working Group and the Phenylalanine Hydroxylase Gene

  2018cites this paper
• [Research progress on phenotype and genotype of hyperphenylalaninemia].

  2018cites this paper
• Relationship between genotype, phenylalanine hydroxylase expression and in vitro activity and metabolic phenotype in phenylketonuria.

  2018cites this paper
• Functional and structural characterisation of 5 missense mutations of the phenylalanine hydroxylase.

  2017cites this paper